Top Markets
#1 Black Phoenix Black Phoenix +167.32%
#2 Islamic Coin Islamic Coin +158.13%
#3 Glidr Glidr +84.34%
#4 Acurast Acurast +40.13%
#5 Cryptopia Cryptopia +22.29%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.49%
#7 Quantum Resistant Ledger Quantum Resistant Ledger +17.26%
#8 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +14.50%
#9 Playnance Playnance +13.58%
#10 OVERTAKE OVERTAKE +13.24%
Coin of the day
Black Phoenix Black Phoenix
Instellingen
Taal
DUTCH
Valuta
USD
Thema
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.

ARYx Therapeutics, Inc.

ARYX
Rang in aandelen #41543
Based in Fremont, California, and established in 1997, ARYx Therapeutics, Inc.... Based in Fremont, California, and established in 1997, ARYx Therapeutics, Inc. is dedicated to discovering and advancing innovative treatments, primarily focusing on widespread, chronic conditions addressable with oral medications. The company utilizes its unique RetroMetabolic Drug Design technology to engineer distinctive molecular compounds that maintain the therapeutic effectiveness of their original counterparts. Its clinical development portfolio includes several promising candidates: Tecarfarin (ATI-5923): An oral anticoagulant currently in Phase III clinical trials, aimed at preventing hazardous blood clots in at-risk patients. Budiodarone (ATI-2042): An oral antiarrhythmic agent undergoing Phase IIb development for managing atrial fibrillation, a form of irregular heart rhythm. ATI-7505: An oral prokinetic agent in Phase IIb clinical development, targeting various gastrointestinal issues such as chronic constipation, gastroparesis, functional dyspepsia, irritable bowel syndrome with constipation, and gastroesophageal reflux disease. ATI-9242: An antipsychotic agent progressing through Phase I clinical trials for the treatment of schizophrenia and other psychiatric conditions. Additionally, ARYx Therapeutics is conducting early-stage research on ATI-20,000 for metabolic disorders and ATI-24,000 for gastrointestinal ailments.
Aandeelprijs
$0.0005
Laatst gesynchroniseerd: 2026-08-11
Marktkapitalisatie
$16.73K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel ARYx Therapeutics, Inc. (ARYX)

Categorie

Healthcare
Aandelsplitsingen voor ARYx Therapeutics, Inc. (ARYX)
Het aandeel ARYx Therapeutics, Inc. (symbool: ARYX) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Aug 13, 2026.
Eén aandeel ARYX dat vóór Aug 13, 2026 werd gekocht, staat nu gelijk aan 0 aandelen ARYX.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 0 -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 0 -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 0 -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 0 -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 5 x119
IN